Oral 5-HT3-receptor antagonists: expanding the options for Medicare outpatients.
Dempsey
C L
CL
Shillington
A C
AC
Goliak
M
M
D000553:Ambulatory Care; D000932:Antiemetics / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D006278:Medicare; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D012051:Reimbursement Mechanisms; D012702:Serotonin Antagonists / Q000191:economics / Q000627:therapeutic use*; D014481:United States; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D000932:Antiemetics; D012702:Serotonin Antagonists